专利药品用英语怎么说,专利药品的英文翻译


词语导航

基本信息

词语:专利药品

繁体:專利藥品

拼音:zhuān lì yào pǐn

英语翻译

【法】 patent medicine

分词翻译

专利的英语翻译:

patent
【化】 patent
【经】 monopolization; monopolize; patent

药品的英语翻译:

medicines and chemical reagents; physic
【医】 medicine

翻译例句

1. 非专利药品是医药产业的祸根。

GENERIC drugs are the scourge of the pharmaceutical industry.

2. 试试这一种新的专利药品吧。

Try some of this new patent medicine.

3. 制造并出口专利药品的可依法获得强制许可;

In case of manufacturing and exporting patented medicine, compulsory license can be obtained;

4. 试试这种专利药品吧。

Try some of this new patent medicine.

5. 专利药品的新药临床实验不构成专利侵权?。

Are Clinical Trials Exempted from Liability for Patent Infringement?

6. 卫生官员无需考虑专利情况就能够购买低价的非专利药品。

Health officials could purchase lower-priced generic medicines without having to consider the patent status.

7. 治疗计划应尽量考虑使用这样的药物,而不是那些天价专利药品。

These drugs should be a focus of cancer treatment programmes, rather than expensive on-patent drugs.

8. 事实上,这个产业把危险的专利药品卖给容易上当的消费者。

In effect, the industry was selling dangerous patent medicine to gullible consumers.

9. 一个印度公司开始向非洲的一个医疗慈善机构折扣出售昂贵专利药品的仿制品。

An Indian company starts to sell discounted copies of expensive patented AIDS drugs to a medical charity in Africa.

10. 仅仅在2010年一年,该行业来自专利药品的15%的税收就将处于风险中。

In 2010 alone the industry will see nearly 15% of its revenue from patented drugs put at risk.

11. 因此,在未经专利权人许可的条件下,进行专利药品的临床试验是允许的。

Thus, clinical trials of a patented medicine will be permitted in the absence of a license from the patent owner.

12. 许多国家如果实行鼓励使用高质量非专利药品政策,可以节省大约60%的药费。

A policy that encourages the use of good quality generic medicines can save around 60% of the costs of medicines in many countries.

13. 目的:为在公共健康危机发生时,能有效降低专利药品价格,提高药品的可获得性。

OBJECTIVE: to lower the price of patent medicine effectively and to increase the access to medicine when public health crises occur.

14. 2013年,占辉瑞目前销售量38%的产品将面临来自非专利药品公司的价格竞争。

By 2013 products accounting for 38% of current sales will be exposed to price competition from generics.

15. 所达成的共识是,在来势凶猛的公众健康紧急情况下,贫穷国家将可以生产非专利药品。Www.wenTiYi.COm

It was agreed that in an overwhelming public health emergency, poor countries would be allowed to produce generic drugs.

16. 目的为完善我国新上市专利药品价格管理提供参考,特研究新上市专利药品定价方法。

To provide reference for improvement in new patent drug pricing and administration in China.

17. 这些非专利药品和专利药完全一样,只是没有品牌名称,也就是不向医药公司支付巨额专利费。

They are the exact same product, but without the brand name — or the fat patent payments to drug companies.

18. 《报告》估计,如果使用非专利药品替代原创产品,那么国家将可以节省60%左右的药品支出。

The report estimates that countries could save about 60% of their pharmaceutical expenditures by shifting from originator medicines to generic products.

19. 虽然这些价格低廉的非专利药品无法治愈患者,但可降低患体病毒活性,使感染者免遭病痛之苦。

These are reasonably cheap, often generic, pharmaceuticals that, although they do not cure someone, do lower the level of the virus in his body to the extent that he suffers no symptoms.

20. 由于2006年是对新非专利药品最好的一年,从该类药品中取得的可观利润看上去也达到了顶点。

The sizeable profits they have made from generics also look as if they will peak, since 2006 is the biggest year for new generic drugs.

21. 从治疗致命疾病的药品到止痛药和抗组胺药等价格低廉的非专利药品,各种药物都有造假的情况出现。

All kinds of medicines have been counterfeited, from medicines for the treatment of life-threatening conditions to inexpensive generic versions of painkillers and antihistamines.

22. 在私立部门,非专利药品的价格比国家参考价格平均高出六倍以上。一般来说,专利品牌药会更加昂贵。

In the private sector, generic medicines cost on average six times more than their international reference price, while originator brands are generally even more expensive.

23. 在44个低收入国家进行的调查表明,仅有44%的公立机构和66%的私立机构有清单所列非专利药品的库存。

Surveys conducted in 44 low-income countries show that 44% of public sector and 66% of private sector outlets had the listed generic medicines in stock.

24. 其实,一旦成为通用的药物,药物代表代表停止促进销售,因为他们都是或部分支付佣金,非专利药品没有佣金。

Actually, once a drug becomes generic, the reps cease promoting it because they are all or partly paid on commission and there is no commission for generic drugs.

25. 在40多个低收入国家进行的调查表明,仅有44%的公共部门和65%的私营部门有清单所列非专利药品的库存。

Surveys conducted in over 40 low-income countries show that 44% of public sector and 65% of private sector outlets had the listed generic medicines in stock.

26. 大制药公司过去总是对非专利药品制造商嗤之以鼻,现在碍于自身利益受到冲击,这些巨头们不得不重新审时度势。

Big drug firms used to turn their noses up at the generics business, but the assault on their profits has forced them to think again.

27. 大制药公司过去总是对非专利药品制造商嗤之以鼻,现在碍于自身利益受到冲击,这些巨头们不得不重新审时度势。

Big drug firms used to turn their noses up at the generics business, but the assault on their profits has forced them to think again.

版权声明:问题易所有作品(图文、音视频)均来源网络,版权归原创作者所有,与本站立场无关,如不慎侵犯了你的权益,请联系我们告知,我们将做删除处理!